Cardiogenic Shock in Critical Care Medicine: The Newest Findings and Challenges

Dear Colleagues,

Cardiogenic Shock in Critical Care Medicine is recognized as one of the most complex challenges, because frequently it is not an easy diagnosis.

It is often associated to other circulatory disorders, correlated to reactive vasoconstriction or vasodilation that worst or improve vitals parameters, delaying its prompt identification.

Moreover, complexity of critical care patients and poor specificity of blood chemistry exams could cloud interpretation of clinical status, and in fact septic shock (the great antagonist) must be excluded or confirmed every time.

In fact, cardiogenic shock and septic shock could coexist increasing the challenge.

This Special Issue has the aim of focusing on recent advances in monitoring, management, therapeutic drugs, and mechanical support in cardiogenic shock in several scenarios, cause cardiogenic shock is in large part caused by primary myocardial dysfunction but cardiac failure could follow other syndromes.

Principal topics:

• Recognizing cardiogenic shock: systolic or diastolic, does it matter?
• Monitoring cardiogenic shock: gold standards or new minimally invasive technology?
• Recent advances in echocardiography, the pivotal role in diagnosis of cardiac dysfunction.
• Levosimendan, useful or useless, perks and pitfalls of a drug.
• Istaroxime, new frontiers of cardiac pharmacology?
• Optimal blood pressure in cardiogenic shock after cardiac arrest, how much is the threshold and how reaching it?
• Early veno-arterial extracorporeal life support in myocardial infarction.
• New endovascular technology for circulatory support.
• Where is the shock? Cardiogenic, septic or both?
• Early management of cardiomyopathy in septic shock.

Dr. Lorenzo Schiavoni
Dr. Marco Marini
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• cardiogenic shock
• invasive and minimally-invasive monitoring
• extracorporeal life support
• inotropes